NASDAQ:ARQT | Income Statement | Arcutis Biotherapeutics, Inc.

Complete source-backed income-statement history.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$129.86M$10.94M$20.36M$82.14M$16.43M-$1.28M$136,000.00$15.01M$0.11$0.11130,522,000135,898,000
2026-03-31$105.4M$9.78M$30.63M$74.08M-$9.09M$93,000.00-$11.3M-$0.09-$0.09129,365129,365
2025-12-31$127.5M$11.69M$20.45M$78.98M$18.39M$470,000.00$17.4M$0.13$0.13342,715342,715
2025-09-30$99.22M$8.69M$19.6M$62.4M$8.53M$80,000.00$7.41M$0.06$0.06127,622,860132,884,567
2025-06-30$81.5M$7.49M$19.45M$69.17M-$14.61M-$933,000.00$342,000.00-$15.89M-$0.13-$0.13126,997,000126,997,000
2025-03-31$63.85M$8.83M$17.54M$64M-$24.53M$279,000.00-$25.06M-$0.20-$0.20126,037126,037
2024-12-31$69.36M$6.91M$14.48M$57.61M-$7.63M$323,000.00-$10.79M-$0.08-$0.081,330,3131,330,313
2024-09-30$44.76M$5.5M$19.5M$58.82M-$39.07M$0.00-$41.54M-$0.33-$0.33124,302,317124,302,317
2024-06-30$30.86M$3.46M$19.3M$58.17M-$50.08M$0.00-$52.33M-$0.42-$0.42123,481,000123,481,000
2024-03-31$21.57M$3.26M$23.14M$54.79M-$31.62M$324,000.00-$35.38M-$0.32-$0.32111,048,525111,048,525
2023-12-31$13.53M$2.25M$23.78M$48.67M-$61.17M$25,000.00-$66.28M-$0.59-$0.597,842,9757,842,975
2023-09-30$8.11M$1.18M$26.24M$47.6M$75.01M-$36.9M$3.02M-$44.77M-$0.73-$0.7361,727,27861,727,278
2023-06-30$4.77M$776,000.00$25.22M$45.96M$71.95M-$66.76M-$4.23M$0.00-$70.99M-$1.16-$1.1661,430,62061,430,620
2023-03-31$2.78M$783,000.00$35.35M$42.92M$79.05M-$76.27M-$3.84M$0.00-$80.1M-$1.31-$1.3161,169,08961,169,089
2022-12-31$2.96M$33.88M$37.02M$71.39M-$68.42M-$3.6M$0.00-$72.02M-$1.14-$1.142,003,3032,003,303
2022-09-30$725,000.00$69.73M$35.47M$105.47M-$104.75M-$2.96M$0.00-$107.71M-$1.89-$1.8957,091,74357,091,743
2022-06-30$0.00$38.21M$27.62M$65.83M-$65.83M-$1.58M-$67.41M-$1.31-$1.3151,422,38651,422,386
2022-03-31$0.00$40.62M$22.01M$62.63M-$62.63M-$1.7M-$64.32M-$1.27-$1.2750,513,52450,513,524
2021-12-31$0.00$52.56M$18.73M$71.29M-$71.29M-$40,000.00-$71.33M-$1.43-$1.43268,807268,807
2021-09-30$0.00$40.6M$16.47M$57.08M-$57.08M$98,000.00-$56.98M-$1.14-$1.1450,097,85150,097,851
2021-06-30$30.77M$42.08M-$42.08M$72,000.00-$42.01M-$0.84-$0.8450,000,71650,000,716
2021-03-31$21.63M$36.09M-$36.09M$43,000.00-$36.04M-$0.76-$0.7647,280,76947,280,769
2020-12-31$27.37M$34.06M-$34.06M$15,000.00-$34.05M-$0.74-$0.742,454,1472,454,147
2020-09-30$32.74M$38.3M-$38.3M$99,000.00-$38.2M-$1.01-$1.0137,748,45437,748,454
2020-06-30$30.01M$35.63M-$35.63M$215,000.00-$35.41M-$0.94-$0.9437,587,33037,587,330
2020-03-31$25.18M$28.65M-$28.65M$638,000.00-$28.01M24,256,402
2019-12-31$10.76M$12.99M-$12.99M$426,000.00-$12.57M70,188
2019-09-30$12.35M$14.65M-$14.65M$168,000.00-$14.48M1,915,601
2019-06-30$7.21M$8.54M-$8.54M$248,000.00-$8.29M1,767,658
2019-03-31$6.2M$6.95M-$6.95M$294,000.00-$6.66M1,632,694

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$372.07M$36.7M$77.05M$274.55M-$12.23M$1.17M-$16.14M-$0.13-$0.13127,234,000127,234,000
2024-12-31$166.54M$19.13M$76.42M$229.39M-$128.4M$647,000.00-$140.04M-$1.16-$1.16120,958,000120,958,000
2023-12-31$29.19M$4.99M$110.58M$185.15M-$241.1M$3.11M-$262.14M-$3.78-$3.7869,305,00069,305,000
2022-12-31$3.69M$754,000.00$182.44M$122.12M$305.31M-$301.63M-$9.83M$0.00-$311.46M-$5.66-$5.6655,032,26555,032,265
2021-12-31$0.00$0.00$145.56M$60.97M$206.53M-$206.53M$173,000.00$0.00-$206.36M-$4.18-$4.1849,405,57549,405,575
2020-12-31$0.00$115.31M$136.65M-$136.65M$967,000.00$0.00-$135.68M-$3.80-$3.8035,668,15235,668,152
2019-12-31$36.52M$43.13M-$43.13M$1.14M$0.00-$42M-$22.78-$22.781,843,2131,843,213
2018-12-31$17.94M$19.74M-$19.74M$480,000.00$0.00-$19.26M1,239,689